TILRAY MEDICAL

Serial Number 97433023
641

Registration Progress

Application Filed
May 27, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Apr 05, 2026 70 days

Trademark Image

TILRAY MEDICAL

Basic Information

Serial Number
97433023
Filing Date
May 27, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
641
Status Date
Jan 5, 2026
Application
Pending
Classes
005 031 041 042
+1 more

Rights Holder

Tilray Brands, Inc.

03
Address
19th Floor
655 Madison Avenue
New York, NY 10065

Ownership History

Tilray Brands, Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
PETER SLOANE

USPTO Deadlines

Next Deadline
70 days remaining
Non-Final Action E-Mailed
Due Date
April 05, 2026
Extension Available
Until July 05, 2026

Application History

50 events
Date Code Type Description Documents
Jan 5, 2026 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 5, 2026 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 5, 2026 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 8, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 8, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 8, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 4, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 2, 2025 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Oct 2, 2025 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Oct 2, 2025 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 14, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 14, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 14, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 5, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 5, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 4, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 4, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Apr 4, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 3, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 16, 2025 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jan 16, 2025 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jan 16, 2025 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 18, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 18, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 18, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 17, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 17, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 17, 2024 ALIE A ASSIGNED TO LIE Loading...
Jan 30, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 16, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Nov 16, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Nov 16, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
May 19, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 19, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
May 19, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 25, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 25, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 31, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 31, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 31, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 4, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...

Detailed Classifications

Class 005
Cannabis related products, namely, medicated oils, salves, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis for medicinal purposes, namely, gummy vitamins for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Class 031
Live cannabis plants; Cannabis seeds for agricultural purposes; derived solely from hemp plants containing no more than .3 percent delta-9 tetrahydrocannabinol (THC) concentration by dry weight basis
Class 041
Providing entertainment information in the field of cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture; providing educational information in the field of cannabis-themed cultural events and festivals via a website
Class 042
Research services, namely, medical, scientific, foods, cosmetic, product, and agricultural research in the area of cannabis, cannabis related products, derivatives of cannabis, and natural health products containing cannabis; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Class 044
Providing the breeding, growing, cultivation, and harvesting of cannabis for others; production of cannabis, namely, cultivation of cannabis plants, for others; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

Additional Information

Design Mark
The mark consists of a stylized sideways "V" with three sun rays radiating out from the center of the "V" and to the right of the "V" the stylized word TILRAY above the word MEDICAL.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 031 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICAL"